Valeritas, Inc.

we are a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. we designed our first commercialized product, the v-go wearable insulin delivery device, or v-go, to help patients with type 2 diabetes who require insulin to achieve and maintain their target blood glucose goals. v-go is indicated for continuous subcutaneous infusion of insulin over 24 hours at preset rates and on-demand bolus dosing in two-unit increments in adult patients requiring insulin. v-go is a small, discreet and easy-to-use disposable insulin delivery device that a patient adheres to his or her skin every 24 hours. v-go enables patients to manage their diabetes with insulin without the need to plan a daily routine around multiple daily injections. v-go enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin (fast-acting) at a continuous preset (background) basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. in numerous real-world analyses v-go has consistently shown to lower a1c’s with less insulin. the discreet and convenient basal-bolus insulin delivery method provided by v-go empowers patients to simplify their insulin management thereby mitigating the need to plan their daily routine around multiple daily injections. v-go is cleared for use in the united states and the e.u. is commercially available in the united states.

E-Mail-Adressen finden

Probieren Sie es schnell mit tomba.io aus. tomba.io.

E-Mail-Adressen aus einer Liste findenMit Google starten